M.D., Assistant Professor, School of Medicine, University of North Carolina
Dr. Patel is a molecular pathologist who focuses on the implementation of next generation sequencing for somatic indications in cancer. Her work at UNC Lineberger Comprehensive Cancer Center includes support for UNCseq, a clinical trial that has enrolled over 2700 patients for large-scale genetic analysis of their tumors with subsequent evaluation utilizing a molecular tumor board. She also serves as a volunteer for professional societies such as the Association for Molecular Pathology and the College of American Pathologists to facilitate education for pathologists and clinicians regarding advanced molecular testing.
Session Synopsis: This session will describe two institutions’ experiences with implementing precision technologies such as NGS for the genetic profiling of cancer, as well as show how a multi-modal approach to understanding cancer ultimately improves care.